Inhibition of SKP2 Sensitizes Bromocriptine-Induced Apoptosis in Human Prolactinoma Cells

PURPOSE: Prolactinoma (prolactin-secreting pituitary adenoma) is one of the most common estrogen-related functional pituitary tumors. As an agonist of the dopamine D2 receptor, bromocriptine is used widely to inhibit prolactinoma progression. On the other hand, it is not always effective in clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Jinxiang, Zhang, Fenglin, Jiang, Lei, Hu, Guohan, Sun, Wei, Zhang, Chenran, Ding, Xuehua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5398389/
https://www.ncbi.nlm.nih.gov/pubmed/27488872
http://dx.doi.org/10.4143/crt.2016.017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5398389/
https://www.ncbi.nlm.nih.gov/pubmed/27488872
http://dx.doi.org/10.4143/crt.2016.017

Ejemplares similares